Intro

This chapter delves into the advantages and practical aspects of long-acting injectable antipsychotics for treating chronic psychotic conditions like schizophrenia. It highlights the differences in usage rates between Europe and the United States, focusing on the challenge of non-adherence and its impact on patient relapse.